Infection and Immunity, September 2000, p. 5261-5268, Vol. 68, No. 9
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
1-4Gal
1-4Glc) Epitope of Moraxella catarrhalis Is
a Factor in Resistance to Bactericidal Activity Mediated by Normal
Human Serum
Departments of Microbiology1 and Internal Medicine,3 The University of Iowa, Iowa City, Iowa; College of Medicine and Department of Pharmaceutical Chemistry, School of Pharmacy, University of California, San Francisco, California2; and Department of Microbiology, State University of New York at Buffalo, Buffalo, New York4
Received 5 April 2000/Returned for modification 5 June 2000/Accepted 13 June 2000
Moraxella catarrhalis is a respiratory pathogen
responsible for acute bacterial otitis media in children and
exacerbation of chronic bronchitis in adults. M. catarrhalis strains are frequently resistant to the bactericidal
activity of normal human serum. In order to determine if the
lipooligosaccharide (LOS) of M. catarrhalis has a role in
serum resistance, the UDP-glucose-4-epimerase (galE) gene
was identified, cloned, and sequenced and a deletion/insertion mutation
was introduced into M. catarrhalis strain 2951. GalE enzymatic activity, measured in whole-cell lysates, was ablated in
M. catarrhalis 2951 galE. Mass spectrometric
analysis of LOS isolated with hot phenol-water confirmed that strain
2951 produced a type A LOS. These studies showed that the LOS from 2951 galE had lost two hexose residues due to the
galE mutation and that the resultant LOS structure lacked
the (Gal
1-4Gal
1-4Glc) Pk epitope found on
M. catarrhalis 2951. Wild-type M. catarrhalis 2951 is resistant to complement-mediated serum bactericidal activity. In contrast, a greater than 2-log10-unit reduction in CFU
occurred after incubation of 2951 galE in either 50 or 25%
pooled human serum (PNHS), and CFU in 10% PNHS decreased by about 1 log10 unit. These studies suggest that the Pk
epitope of the LOS may be an important factor in the
resistance of M. catarrhalis to the complement-mediated
bactericidal effect of normal human serum.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|